| Names | |
|---|---|
| Preferred IUPAC name 1-(3-{4-[(piperidin-1-yl)methyl]phenoxy}propyl)piperidine | |
| Identifiers | |
3D model (JSmol) | |
| Abbreviations | JNJ-5207852 |
| ChEMBL | |
| ChemSpider | |
| MeSH | JNJ-5207852 |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C20H32N2O | |
| Molar mass | 316.480 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
JNJ-5207852 is a histamine antagonist selective for the H3 subtype. It has stimulant and nootropic effects in animal studies, [1] and has been suggested as a possible treatment for some memory defects associated with epilepsy. [2] JNJ-5207852 itself did not progress to clinical development due to poor pharmacokinetic characteristics, but the related compound JNJ-17216498 was in a Phase II clinical trial for the treatment of narcolepsy in 2007. [3]